article thumbnail

SpeeDx Build Further Coverage in SARS-CoV-2 Genotyping Reagent Portfolio

BioTech 365

SpeeDx Build Further Coverage in SARS-CoV-2 Genotyping Reagent Portfolio SpeeDx Build Further Coverage in SARS-CoV-2 Genotyping Reagent Portfolio Rapid development of key mutation detection reagents continues to facilitate critical investigation and monitoring activities SYDNEY–(BUSINESS WIRE)–#COVID19–SpeeDx Pty.

article thumbnail

Roche signs definitive share purchase agreement with long-term partner TIB.

The Pharma Data

TIB Molbiol is a biotech company that has supplied the global market with reagents for research and medical diagnostics for over 30 years. To support customers performing human genotyping, TIB Molbiol provides custom made LightSNiP assays for SNP analysis. About TIB Molbiol.

article thumbnail

Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

The Pharma Data

3, and Delta ([link] About TIB Molbiol TIB Molbiol is a subsidiary of Roche Diagnostics that has supplied the global market with reagents for research and medical diagnostics for over 30 years. To support customers performing human genotyping, TIB Molbiol provides custom-made LightSNiP assays for SNP analysis.